Sign up to save your podcasts
Or
Share S3:E1 – Non-Small Cell Lung Cancer Morning Commute: The Newly Diagnosed Patient
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
S3:E1 – Non-Small Cell Lung Cancer Morning Commute: The Newly Diagnosed Patient
Visit MorningCommutePodcast.com/NSCLC1 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode our experts discuss the current standards of care regarding patient work-up, diagnosis, as well as PD-L1 expression and emerging immunotherapy biomarkers in treatment selection for non-small cell lung cancer.
View all episodes
By @Point of Care
5
1616 ratings
Visit MorningCommutePodcast.com/NSCLC1 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode our experts discuss the current standards of care regarding patient work-up, diagnosis, as well as PD-L1 expression and emerging immunotherapy biomarkers in treatment selection for non-small cell lung cancer.